ロード中...
COVID-19, hydroxychloroquine and sudden cardiac death: implications for clinical practice in patients with rheumatic diseases
Sudden cardiac death is commonly seen due to arrhythmias, which is a common cardiac manifestation seen in COVID-19 patients, especially those with underlying cardiovascular disease (CVD). Administration of hydroxychloroquine (HCQ) as a potential treatment option during SARS-CoV-2, initially gained p...
保存先:
| 出版年: | Rheumatol Int |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Berlin Heidelberg
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7775739/ https://ncbi.nlm.nih.gov/pubmed/33386447 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00296-020-04759-2 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|